FER (feline encephalitis virus-related kinase) is a non-receptor tyrosine kinase involved in:
Immune response modulation via B-cell and T-cell signaling .
Oncogenic signaling pathways, particularly in colon and hepatic carcinomas .
Phosphorylation at Y402 is a key activation marker, enabling interactions with downstream signaling proteins like SRC and MDM2 .
Phospho-FER (Y402) antibodies are typically raised in rabbits using synthetic phosphopeptides corresponding to the Y402 region . Key validation steps include:
Western blotting: Detects ~85–95 kDa bands in human and mouse lysates .
Immunohistochemistry (IHC): Localizes phosphorylated FER in formalin-fixed tissues, such as brain and carcinoma samples .
Preabsorption controls: Phosphopeptide preincubation abolishes signal, confirming specificity .
To ensure reliability, manufacturers employ rigorous validation:
Phosphatase treatment: Alkaline phosphatase pretreatment reduces antibody binding, confirming phosphorylation dependence .
Genetic controls: Knockout cell lines or tissues show no signal .
Cross-reactivity: No reactivity with dephosphorylated FER or unrelated phosphoproteins (e.g., ERK1/2) .
Mechanistic studies: Phospho-FER (Y402) antibodies identify hyperactivation in colon carcinoma metastases and hepatocellular carcinoma cell lines .
Therapeutic targeting: Used to evaluate kinase inhibitor efficacy in preclinical models .
Neurodegeneration: Investigates FER’s role in tau phosphorylation and Alzheimer’s disease pathways .
Oncogenic role: Elevated Y402 phosphorylation correlates with tumor progression and poor prognosis in colorectal cancer .
Crosstalk with SRC: Phospho-FER (Y402) recruits SRC to focal adhesions, promoting cell invasion .
Inflammatory pathways: Mediates macrophage polarization and cytokine production in murine models .
Fixation sensitivity: Prolonged formalin fixation may mask epitopes, requiring optimized retrieval protocols .
Batch variability: Polyclonal antibodies may exhibit lot-to-lot differences .